Zur Rose Group AG: Takeover of apo-rot's mail-order activities successfully completed Mittwoch, 31. Oktober 2018 - 07:01

Zur Rose Group AG / Key word(s): Alliance
Zur Rose Group AG: Takeover of apo-rot's mail-order activities successfully
completed

31.10.2018 / 07:00

---------------------------------------------------------------------------

Press release

Zur Rose Group: Takeover of apo-rot's mail-order activities successfully
completed

The Zur Rose Group successfully completed the takeover of apo-rot's
mail-order activities. With this step, the Group continues to consolidate
the largest European mail order market Germany and systematically expands
its leadership position in Europe.

Investors and analyst contact
Marcel Ziwica, Chief Financial Officer
Email: ir@zurrose.com, phone: +41 58 810 11 49

Media contact
Lisa Lüthi, Head of Corporate Communications
Email: media@zurrose.com, phone: +41 52 724 08 14

Financial Calendar
19 November 2018 Extraordinary General Meeting
23 January 2019 Sales 2018
21 March 2019 Annual results 2018
17 April 2019 Q1/2019 Trading Update
23 May 2019 Annual General Meeting

Zur Rose Group

The Swiss Zur Rose Group is Europe's largest online pharmacy and one of the
leading medical wholesalers in Switzerland. With its business model, it
offers high-quality, safe and cost-effective pharmaceutical care and thus
contributes to reducing healthcare costs. It is also characterized by the
continuous further development of digital services in the field of drug
management in order to increase therapy safety. The creation of added value
and a pronounced patient orientation make the Group an important strategic
partner for service providers, cost units and industry.

The Zur Rose Group is internationally present with strong brands, including
Germany's best-known pharmacy brand DocMorris. The company employs over
1,000 people at various locations and generated a turnover of CHF 983
million in the 2017 financial year. The shares of Zur Rose Group AG are
listed on the SIX Swiss Exchange (securities number 4261528, ISIN
CH0042615283, ticker ROSE). The CHF 115 million corporate bond issued in
July 2018 is also listed on the SIX Swiss Exchange (securities number
42146044, ISIN CH0421460442, ticker ZRO18). Further information at
zurrosegroup.com